Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.
Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.
Microglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In Vivo.
Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.
Pangaea 2.0: State Of The Art Multiple Sclerosis Patient Management In Daily Clinical Practice. A New 3-Year Observational Study Of Patients Receiving Fingolimod.
Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination.
Epigallocatechin-3-gallate rescues LPS-impaired adult hippocampal neurogenesis through suppressing the TLR4-NF-κB signaling pathway in mice.
Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures.
White matter disease: Aquaporin-4 antibody-positive patients may not always fulfil the clinical criteria for neuromyelitis optica.
Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in taiwan.
Vitamin d: shining a light on clinical and sex specific effects in multiple sclerosis?
Comment on: 'Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients'
Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry.
The Stress-Buffering Effects of Hope on Adjustment to Multiple Sclerosis.
[Locomotive syndrome and Frailty. Vitamin D and Frailty].
A comparison of linear and nonlinear stability parameters in different clinical forms of multiple sclerosis.
Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.
Obstructive Sleep Apnea is an Under-Recognized and Consequential Morbidity in Multiple Sclerosis.
Heterodimerization of p45-p75 Modulates p75 Signaling: Structural Basis and Mechanism of Action.
Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis.
Complex I Subunit Gene Therapy with NDUFA6 Ameliorates Neurodegeneration in EAE.
Dimethyl fumarat - a new player in oral treatment options for relapsing forms of multiple sclerosis.
Glatiramer acetate-induced lobular panniculitis and skin necrosis.
Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions.
Casein kinases as potential therapeutic targets.
Pages
« first
‹ previous
…
648
649
650
651
652
653
654
655
656
…
next ›
last »